Hospital Universitario Puerto Real   Report issue

Academic/Hospital Phase 4
Founded: Cádiz Spain (1990)

Organization Overview

First Clinical Trial
2012
NCT01849341
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Alternative names

Hospital Universitario de Puerto Real

Active Ingredients

Drugs in Phase 4 Trials (1)

roflumilast (daliresp) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Lung Diseases, Obstructive (Phase 4)

Pulmonary Disease, Chronic Obstructive (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 1